Bausch + Lomb Corporation

BLCO.TOTSXHealthcare● Active

$21.18

$-0.46(-2.13%)

Market Cap$7.6B

P/E Ratio—

52W High$25.7

52W Low$15.69

Avg Volume2K

Open$21.49

Beta0.57

Free Cash Flow Financials Revenue

Bausch + Lomb Corporation (BLCO.TO) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

BLCO.TO · free cash flow · updated Jun 8, 2026

Core FCF metrics

BLCO.TO · FCF · TTM · margin & CAGR

Free cash flow was −$66.0M for FY2025 (fiscal year ending 2025-12-31), down 11.9% year-over-year The FCF margin was -1.3%.

FY2025 Free Cash Flow−$66.0M▼ -11.9% YoY

Trailing 12M (TTM)$4.5MTrailing 4Q sum · TTM positive vs latest FY negative

FCF Margin-1.3%−$66.0M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

BLCO.TO · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$283.0M(349M)−$66.0M▼ 11.9%-1.3%

FY2024$232.0M(291M)−$59.0M▲ +70.2%-1.2%

FY2023−$17.0M(181M)−$198.0M▼ 216.5%-4.8%

FY2022$345.0M(175M)$170.0M▼ 74.4%4.5%

FY2021$873.0M(209M)$664.0M▲ +152.5%17.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

BLCO.TO · P/FCF · FCF yield · FCF per share

Bausch + Lomb Corporation (BLCO.TO) trades at a FCF yield of 0.08% and a price-to-free-cash-flow ratio of 2118.0x. FCF per share stands at $0.01, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

0.08%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.01

TTM FCF ÷ Shares Outstanding

Price / FCF

x2118.0

Share Price ÷ FCF per Share

EV / FCF (TTM)

x1203.0

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

BLCO.TO · cash flow statement · operating / investing / financing

For FY2025, Bausch + Lomb Corporation generated $283.0M in operating cash flow and spent 349M in capital expenditures, yielding −$66.0M in free cash flow.

Operating Activities

+$283.0M

Cash from core business operations

2025-12-31

Investing Activities

−$455.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$225.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($283.0M) − |CapEx| (349M) = FCF (−$66.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

BLCO.TO vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Bausch + Lomb CorporationYOU

BLCO.TO

−$66.0M-11.9%-1.3%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Bausch + Lomb Corporation (BLCO.TO) reported free cash flow of −$66.0M for FY2025 (fiscal year ending 2025-12-31), down 11.9% year-over-year. The FCF margin was -1.3%.

Based on available data, Bausch + Lomb Corporation has maintained positive free cash flow for at least 5 fiscal year(s). FCF peaked at $664.0M in FY2021.

Bausch + Lomb Corporation's FCF yield is 0.08% and price-to-FCF ratio is 2118.0x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

BLCO.TO free cash flow · 8 questions

Bausch + Lomb Corporation free cash flow was −$66.0M for FY2025, down 11.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $4.5M.

BLCO.TO free cash flowBLCO.TO FCFBLCO.TO FCF 2025BLCO.TO free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Bausch + Lomb Corporation · Bausch + Lomb Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026